The constant reassessment of business practices is necessary to ensure that practitioners are not wasting valuable time, resources, and effort on activities that are not producing the desired results.
CDI remains an urgent public health threat and continues to be the most frequent cause of diarrhea among hospitalized patients and overall hospital-acquired infection in the United States.
Readmission rates for patients receiving OPAT are reported to be as high as 20%, mostly due to catheter-related problems, adverse drug reactions, or worsening of the primary infection.
The quick Pitt Bacteremia Score offers accuracy comparable to the original version's across multiple infections, and maintains ease of use.
Quick action was needed against this very rare cause of fungal endocarditis.
The results of a new study demonstrate that PrEP can reduce new infections within a population even when the risk of HIV remains high and other proven treatment and prevention strategies are optimized.
Jones offered his insights for discharging patients as well as follow-up outpatient treatment.
Despite concerning findings and warnings, fluoroquinolones have remained one of the world’s most commonly prescribed antibiotic classes, with the United States accounting for more than 32 million prescriptions in 2015 alone.
Implants are promising for long-term, sustained, and reversible delivery of ARV drugs that may bypass adherence challenges for end users.
Catheter-associated urinary tract infections (CAUTIs) account for about 40% of all nosocomial infections in hospitals and nursing homes.
Being immunocompromised increases risk of rare Mycobacterium tuberculosis epididymo-orchitis.
A patient presented with a history of uncontrolled HIV and a history of polysubstance use.
Investigators are dusting off angiotensin II and ascorbic acid for renewed use in treating sepis and septic shock.
Experts weigh in on what Congress is doing to tackle the threat of antibiotic resistance.
Expanding the differential for diarrhea beyond Clostridium difficile.
Treatment-experienced patients still have some good options.
A review of the neutralizing antibody that was studied in a phase 2/3 trial in outpatients with mild to moderate infections of COVID-19.
The story of an early-infected US physician who launched a non-profit, participated in trials, and guided her peers after overcoming infection.
In this narrative review of studies evaluating antiretroviral stewardship programs (ARVSPs), we propose core elements for ARVSPs that are based on published evidence, clinical experience, and adapted from antimicrobial stewardship programs.
Treatment with a combination of tenofovir and pegylated interferon yielded higher rates of hepatitis B surface antigen (HBsAg) loss than when either drug was used singly. Further, with longer therapy duration improved results.
Researchers have found that individuals with cytomegalovirus retinitis have a more advanced HIV infection than individuals with ocular syphilis.
Pharmacists can play an important role in managing the use of these medications in patients, particularly those with high blood pressure.
A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.
Researchers safely infuse engineered immune cells in groundbreaking gene therapy study.
Evidence is accumulating that influenza vaccination protection wanes over the course of a single influenza season, with significant implications for public health.
Investigators from the University of California San Diego Medical School report on the first case of Gardnerella bacteremia in an HIV-positive male following the placement of a urinary catheter.
A new trial conducted in England has discovered a cost-effective way to reduce the overprescribing of antibiotics by general practitioners (GPs).
Moving away from the standard course of IV antibiotics.